Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer

Bibliographic Details
Main Authors: Ioannis Alagkiozidis, Melissa Lozano, Mithun Devraj, Yi-Chun Lee, Ovadia Abulafia
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578914000484
id doaj-a1ace11f848d4a36b94f331e9a2f748e
record_format Article
spelling doaj-a1ace11f848d4a36b94f331e9a2f748e2020-11-24T22:28:21ZengElsevierGynecologic Oncology Reports2352-57892015-04-0112C232610.1016/j.gore.2014.12.004Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancerIoannis AlagkiozidisMelissa LozanoMithun DevrajYi-Chun LeeOvadia Abulafiahttp://www.sciencedirect.com/science/article/pii/S2352578914000484MetronomicBevacizumabCyclophosphamideEndometrioid
collection DOAJ
language English
format Article
sources DOAJ
author Ioannis Alagkiozidis
Melissa Lozano
Mithun Devraj
Yi-Chun Lee
Ovadia Abulafia
spellingShingle Ioannis Alagkiozidis
Melissa Lozano
Mithun Devraj
Yi-Chun Lee
Ovadia Abulafia
Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
Gynecologic Oncology Reports
Metronomic
Bevacizumab
Cyclophosphamide
Endometrioid
author_facet Ioannis Alagkiozidis
Melissa Lozano
Mithun Devraj
Yi-Chun Lee
Ovadia Abulafia
author_sort Ioannis Alagkiozidis
title Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_short Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_full Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_fullStr Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_full_unstemmed Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_sort metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
publisher Elsevier
series Gynecologic Oncology Reports
issn 2352-5789
publishDate 2015-04-01
topic Metronomic
Bevacizumab
Cyclophosphamide
Endometrioid
url http://www.sciencedirect.com/science/article/pii/S2352578914000484
work_keys_str_mv AT ioannisalagkiozidis metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT melissalozano metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT mithundevraj metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT yichunlee metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT ovadiaabulafia metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
_version_ 1725746513162797056